BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 23436661)

  • 1. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
    Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
    Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE
    Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature.
    Goldenberg I; Shechter M; Matetzky S; Jonas M; Adam M; Pres H; Elian D; Agranat O; Schwammenthal E; Guetta V
    Eur Heart J; 2004 Feb; 25(3):212-8. PubMed ID: 14972421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].
    Vallero A; Cesano G; Pozzato M; Garbo R; Minelli M; Quarello F; Formica M
    G Ital Nefrol; 2002; 19(5):529-33. PubMed ID: 12439841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abbreviated dosing of N-acetylcysteine prevents contrast-induced nephropathy after elective and urgent coronary angiography and intervention.
    Ochoa A; Pellizzon G; Addala S; Grines C; Isayenko Y; Boura J; Rempinski D; O'Neill W; Kahn J
    J Interv Cardiol; 2004 Jun; 17(3):159-65. PubMed ID: 15209578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis of contrast-induced nephropathy in patients undergoing coronary angiography.
    MacNeill BD; Harding SA; Bazari H; Patton KK; Colon-Hernadez P; DeJoseph D; Jang IK
    Catheter Cardiovasc Interv; 2003 Dec; 60(4):458-61. PubMed ID: 14624421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
    Boccalandro F; Amhad M; Smalling RW; Sdringola S
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):336-41. PubMed ID: 12594698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy.
    Allaqaband S; Tumuluri R; Malik AM; Gupta A; Volkert P; Shalev Y; Bajwa TK
    Catheter Cardiovasc Interv; 2002 Nov; 57(3):279-83. PubMed ID: 12410497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: a randomized trial.
    Fung JW; Szeto CC; Chan WW; Kum LC; Chan AK; Wong JT; Wu EB; Yip GW; Chan JY; Yu CM; Woo KS; Sanderson JE
    Am J Kidney Dis; 2004 May; 43(5):801-8. PubMed ID: 15112170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial.
    Merten GJ; Burgess WP; Gray LV; Holleman JH; Roush TS; Kowalchuk GJ; Bersin RM; Van Moore A; Simonton CA; Rittase RA; Norton HJ; Kennedy TP
    JAMA; 2004 May; 291(19):2328-34. PubMed ID: 15150204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of radiocontrast-induced nephropathy with N-acetylcysteine in patients undergoing coronary angiography.
    Tadros GM; Mouhayar EN; Akinwande AO; Campbell B; Wood C; Blankenship JA
    J Invasive Cardiol; 2003 Jun; 15(6):311-4. PubMed ID: 12777667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography.
    Durham JD; Caputo C; Dokko J; Zaharakis T; Pahlavan M; Keltz J; Dutka P; Marzo K; Maesaka JK; Fishbane S
    Kidney Int; 2002 Dec; 62(6):2202-7. PubMed ID: 12427146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty.
    Mueller C; Buerkle G; Buettner HJ; Petersen J; Perruchoud AP; Eriksson U; Marsch S; Roskamm H
    Arch Intern Med; 2002 Feb; 162(3):329-36. PubMed ID: 11822926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity.
    Briguori C; Colombo A; Airoldi F; Violante A; Castelli A; Balestrieri P; Paolo Elia P; Golia B; Lepore S; Riviezzo G; Scarpato P; Librera M; Focaccio A; Ricciardelli B
    J Am Coll Cardiol; 2004 Aug; 44(4):762-5. PubMed ID: 15312855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Captopril for prevention of contrast-induced nephropathy in diabetic patients: a randomised study.
    Gupta RK; Kapoor A; Tewari S; Sinha N; Sharma RK
    Indian Heart J; 1999; 51(5):521-6. PubMed ID: 10721643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous hemodialysis during coronary angiography fails to prevent radiocontrast-induced nephropathy in chronic renal failure.
    Frank H; Werner D; Lorusso V; Klinghammer L; Daniel WG; Kunzendorf U; Ludwig J
    Clin Nephrol; 2003 Sep; 60(3):176-82. PubMed ID: 14524580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study.
    Baker CS; Wragg A; Kumar S; De Palma R; Baker LR; Knight CJ
    J Am Coll Cardiol; 2003 Jun; 41(12):2114-8. PubMed ID: 12821233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcysteine for prevention of contrast nephropathy: meta-analysis.
    Birck R; Krzossok S; Markowetz F; Schnülle P; van der Woude FJ; Braun C
    Lancet; 2003 Aug; 362(9384):598-603. PubMed ID: 12944058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcysteine, coronary procedure and prevention of contrast-induced worsening of renal function: which benefit for which patient?
    Kefer JM; Hanet CE; Boitte S; Wilmotte L; De Kock M
    Acta Cardiol; 2003 Dec; 58(6):555-60. PubMed ID: 14713182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inorganic nitrate benefits contrast-induced nephropathy after coronary angiography for acute coronary syndromes: the NITRATE-CIN trial.
    Jones DA; Beirne AM; Kelham M; Wynne L; Andiapen M; Rathod KS; Parakaw T; Adams J; Learoyd A; Khan K; Godec T; Wright P; Antoniou S; Wragg A; Yaqoob M; Mathur A; Ahluwalia A
    Eur Heart J; 2024 May; 45(18):1647-1658. PubMed ID: 38513060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.